KRRO Korro Bio Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: KRRO

Price (delayed)

$9.83

Market cap

$144.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$10

Enterprise value

$162.06M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 27
Highlights
KRRO's quick ratio has surged by 61% year-on-year and by 18% since the previous quarter
Korro Bio's debt has decreased by 5% YoY
KRRO's net income is down by 17% year-on-year but it is up by 6% since the previous quarter
KRRO's EPS is up by 14% QoQ but it is down by 2.6% YoY
Korro Bio's gross profit has plunged by 62% YoY and by 38% from the previous quarter
Korro Bio's revenue has shrunk by 62% YoY and by 38% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.frequencytx.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of KRRO

KRRO stock price

How has the Korro Bio stock price performed over time
Intraday
-4.93%
1 week
-28.92%
1 month
-25.42%
1 year
-72.26%
YTD
22.72%
QTD
-25.42%

Financial performance

How have Korro Bio's revenue and profit performed over time
Revenue
$2.38M
Gross profit
$2.38M
Operating income
-$110.18M
Net income
-$106.64M
Gross margin
100%
Net margin
-4,477.1%
KRRO's operating margin has shrunk by 195% YoY and by 52% QoQ
Korro Bio's gross profit has plunged by 62% YoY and by 38% from the previous quarter
Korro Bio's revenue has shrunk by 62% YoY and by 38% QoQ
Korro Bio's net margin has plunged by 52% from the previous quarter

Price vs fundamentals

How does KRRO's price correlate with its fundamentals

Growth

What is Korro Bio's growth rate over time

Valuation

What is Korro Bio stock price valuation
KRRO P/E details
P/E
N/A
P/B
1.37
P/S
72.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
68.04
KRRO's EPS is up by 14% QoQ but it is down by 2.6% YoY
The stock's price to book (P/B) is 37% less than its last 4 quarters average of 2.3 and 10% less than its 5-year quarterly average of 1.6
Korro Bio's equity has decreased by 14% from the previous quarter and by 10% YoY
Korro Bio's revenue has shrunk by 62% YoY and by 38% QoQ
The stock's price to sales (P/S) is 50% more than its last 4 quarters average of 51.1

Efficiency

How efficient is Korro Bio business performance
The return on equity has dropped by 86% year-on-year but it is up by 3.1% since the previous quarter
KRRO's return on assets has dropped by 60% year-on-year but it is up by 3.4% since the previous quarter
KRRO's ROS has shrunk by 51% QoQ
KRRO's ROIC is down by 43% YoY but it is up by 5% from the previous quarter

Dividends

What is KRRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KRRO.

Financial health

How did Korro Bio financials performed over time
The total assets is 171% greater than the total liabilities
KRRO's quick ratio has surged by 61% year-on-year and by 18% since the previous quarter
The current ratio has soared by 60% YoY and by 17% from the previous quarter
Korro Bio's debt is 59% less than its equity
KRRO's debt to equity is up by 14% since the previous quarter and by 5% year-on-year
Korro Bio's equity has decreased by 14% from the previous quarter and by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.